Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Cardiovascular Diseases (CVD) & Metabolic Syndrome (MetS)

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Metabolic Syndrome (MetS) can be a contributing factor to the development of Cardiovascular Diseases (CVD).
Lozupone et al. 2012 Nature 489(7415): 220-230
Li et al. 2021v Front Cardiovasc Med. 8: 704145

Similarly to Metabolic Syndrome (MetS), most deaths among NAFLD patients are attributable to Cardiovascular Diseases (CVD)
Lozupone et al. 2012 Nature 489 (7415): 220-230

References (Sources)

Diversity, stability and resilience of the human gut microbiota
Lozupone et al. 2012 Nature 489(7415): 220-230
Review
Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis
Li et al. 2021v Front Cardiovasc Med. 8: 704145
Review

AI Chat

12/16/2025

Chat with our artificial intelligence:

Start chat!

Cardiovascular Diseases (CVD) & Metabolic Syndrome (MetS)

Welcome to meRfi-GM!

Navigation

Contents

References (Sources)

AI Chat